CONMED (CNMD) CIO sells 257 shares at $41.21 in Form 4

Rhea-AI Filing Summary

CONMED Corp (CNMD) reported an insider stock transaction by its Chief Information Officer. On 11/21/2025, the officer sold 257 shares of CONMED common stock in an open market transaction at a price of $41.21 per share. Following this sale, the filing shows the officer beneficially owning 0 shares directly.

This is a routine Form 4 disclosure required by U.S. securities laws whenever company insiders buy or sell the company’s stock. It does not, by itself, explain the officer’s reasons for the transaction or signal any change in the company’s business operations.

Insider Trade Summary

Net Seller: 257 shares

Net Sell 1 txn

Insider Glaze Richard

Role Chief Information Officer

Sold 257 shs ($11K)

Type	Security	Shares	Price	Value
Sale	Common Stock	257	$41.21	$11K

Holdings After Transaction: Common Stock — 0 shares (Direct)

FAQ

What insider transaction did CONMED Corp (CNMD) report?

CONMED Corp reported that its Chief Information Officer executed a sale of 257 shares of CONMED common stock on 11/21/2025.

At what price were the CONMED (CNMD) shares sold in this Form 4?

The 257 CONMED common shares were sold at a price of $41.21 per share, as disclosed in the Form 4.

How many CONMED (CNMD) shares does the officer own after this transaction?

After the reported sale, the Form 4 lists the officer as beneficially owning 0 shares of CONMED common stock directly.

Who is the insider involved in this CONMED (CNMD) Form 4 filing?

The insider is an officer of CONMED Corp serving as Chief Information Officer, as indicated in the relationship section.

What type of SEC form is this CONMED (CNMD) filing?

This disclosure is a Form 4, which reports changes in the beneficial ownership of CONMED securities by company insiders.

Does this CONMED (CNMD) Form 4 indicate a Rule 10b5-1 trading plan?

The form includes a checkbox for indicating transactions under a Rule 10b5-1(c) plan, but the excerpt does not show whether it was checked.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/24/2025 - 01:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glaze Richard

(Last) (First) (Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO FL 33773

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Information Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/21/2025		S		257	D	$41.21	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Thomas Fistek for Richard Glaze by Power of Attorney	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.